Association of maternal serum α-fetoprotein with persistent placenta previa

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 16, Issue 1, 2004, Pages 3-7

  Koster, E L ^a   Dashe, J S ^a   McIntire, D D ^a   Ramus, R M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Maternal serum fetoprotein; Persistent placenta previa

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ARTICLE; CESAREAN SECTION; CHILDBIRTH; COHORT ANALYSIS; DELIVERY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; GESTATIONAL AGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MATERNAL CARE; OUTCOMES RESEARCH; PLACENTA PREVIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK; RISK REDUCTION; SECOND TRIMESTER PREGNANCY;

ALPHA-FETOPROTEINS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; PLACENTA PREVIA; PREGNANCY; PREGNANCY OUTCOME;

EID: 4644337353     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.1080/14767050410001728935     Document Type: Article

References (18)

1. Rizos N, Doran TA, Miskin M, et al. Natural history of placenta previa ascertained by diagnostic ultrasound. Am J Obstet Gynecol 1979;133:287-91
2. Mittelstaedt CA, Partain CL, Boyce IL, Daniel EB. Placenta previa: significance in the second trimester. Radiology 1979;131:465-8
3. Comeau J, Shaw L, Marcell CC, Lavery JP. Early placenta previa and delivery outcome. Obstet Gynecol 1983;61:577-80
4. King DL. Placental migration demonstrated by ultrasonography. Radiology 1973;109:167-70
5. Wexler P, Gottesfeld KR. Second trimester placenta previa; an apparently normal placentation. Obstet Gynecol 1977; 50:706-9
6. Fleischer AC, Kurtz AB, Wapner RJ, et al. Elevated α-fetoprotein and a normal fetal sonogram: association with placental abnormalities. AJR Am J Roentgenol 1988;150: 881-3
7. Perkes EA, Baim RS, Goodman KJ, Macri JN. Second-trimester placental changes associated with elevated maternal serum α-fetoprotein. Am J Obstet Gynecol 1982;144: 935-8
8. Salafia CM, Silberman L, Herrera NE, Mahoney MJ. Placental pathology at term associated with elevated midtrimester serum α-fetoprotein concentration. Am J Obstet Gynecol 1988;158:1064-6
9. Kelly RB, Nyberg DA, Mack LA, et al. Sonography of placental abnormalities and oligohydramnios in women with elevated α-fetoprotein levels: comparison with control subjects. AJR Am J Roentgenol 1989;153:815-19
10. Berkeley AS, Killackey MA, Cederqvist LL. Elevated maternal serum α-fetoprotein levels associated with breakdown in fetal - maternal - placental barrier. Am J Obstet Gynecol 1983;146:859-61
11. Butler EL, Dashe JS, Ramus RM. Association between maternal serum α-fetoprotein and adverse outcomes in pregnancies with placenta previa. Obstet Gynecol 2001; 97:35-8
12. Department of Clinical Epidemiology and Biostatistics, McMater University, Hamilton, Ontario. Interpretation of diagnostic data 4: how to do it with a more complex table. Can Med Assoc J 1983;129:832-5
13. Zelop C, Nadel A, Frigoletto FD, et al. Placenta accreta/percreta/ increta: a cause of elevated maternal serum α-fetoprotein. Obstet Gynecol 1992;80:693-4
14. Kupfermine MJ, Tamura RK, Wigton TR, et al. Placenta accreta is associated with elevated maternal serum α-fetoprotein. Obstet Gynecol 1993;82:266-9
15. Naeye RL. Placenta previa: predisposing factors and effects on the fetus and surviving infants. Obstet Gynecol 1978;52:521-5
16. Ananth CV, Smulian JC, Vintzileos AM. The association of placenta previa with history of Cesarean delivery and abortion; a meta-analysis. Am J Obstet Gynecol 1997;177: 1071-8
17. Zelop CC, Bromley B, Frigoletto FD, Benacerraf BR. Second trimester sonographically diagnosed placenta previa: prediction of persistent previa at birth. Int J Gynecol Obstet 1994;44:207-10
18. Lauria MR, Smith RS, Treadwell MC, et al. The use of second trimester transvaginal sonography to predict placenta previa. Ultrasound Obstet Gynecol 1996;8:337-40